Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

ZOLL Developed First-of-its-Kind Remedē System for MRI Conditional Use

ZOLL developed remedē System to help treat adults with moderate to severe Central Sleep Apnea (CSA) with magnetic resonance imaging (MRI). Full-body MRI approval allows for comprehensive MRI scans to be performed on individuals who are either new remedē patients or those who already have a remedē device implanted....

Thermo Fisher Scientific Discovered Novel Immunoassays for Preeclampsia

Thermo Fisher Scientific discovered novel biomakers such as B·R·A·H·M·S PlGF plus KRYPTOR and B·R·A·H·M·S sFlt-1 KRYPTOR. ...

Merus Discovered Novel Zenocutuzumab (Zeno) for the treatment of NRG1+ Pancreatic Cancer

Merus discovered zenocutuzumab (Zeno), a novel treatment specifically designed for patients with advanced unresectable or metastatic NRG1 fusion (NRG1+) pancreatic cancer. ...

ELEVIDYS, Novel Gene Therapy Developed for the Tretament of Duchenne Muscular Dystrophy

Sarepta Therapeutics developed a novel gene therapy called ELEVIDYS (delandistrogene moxeparvovec-rokl) for the treatment of ambulatory paediatric patients aged 4 through 5 years with Duchenne muscular dystrophy (DMD) who have a confirmed mutation in the DMD gene....

Novel PRGN-2012 AdenoVerse™ Immunotherapy Discovered for Recurrent Respiratory Papillomatosis

Precigen discovered novel PRGN-2012 AdenoVerse™ Immunotherapy designed specifically for patients suffering from recurrent respiratory papillomatosis. ...

Grünenthal Developed Novel Resiniferatoxin for the Treatment of Knee Osteoarthritis

Grünenthal developed novel resiniferatoxin (RTX), for the pain associated with osteoarthritis (OA) of the knee which is currently undergoing clinical Phase III development....

First-of-its-Kind Omnipod GO™ Introduced for Type 2 Diabetes

Insulet Corporation introduced new Omnipod GO™, an insulin delivery device for people 18 years of age or older with type 2 diabetes who typically take daily long-acting insulin injections....

Boehringer Ingelheim Discovered Novel SPEVIGO® for the Treatment of Psoriasis Flares

Boehringer Ingelheim discovered novel spesolimab (marketed as SPEVIGO®) for the prevention of flares in adolescents and adults with generalised pustular psoriasis (GPP)....

SAB Biotherapeutics Developed Novel SAB-176 Influenza Immunotherapy

SAB Biotherapeutics has developed novel SAB-176, an investigational drug for post-exposure prophylaxis of influenza A and B in high-risk patients, including those with resistant strains of the virus....

CEQUA®, Novel Therapy Discovered for Dry Eye Disease

Sun Pharmaceutical Industries dicovered CEQUA®, a novel therapy for the treatment of dry eye disease....